J. Liu et al., SUPPRESSION OF LIVER CYTOCHROME-P450 BY ALPHA-HEDERIN - RELEVANCE TO HEPATOPROTECTION, Toxicology and applied pharmacology, 134(1), 1995, pp. 124-131
This study was designed to determine the protective effects of alpha-h
ederin on chemical-induced liver injury in CF-1 mice and to evaluate c
ytochrome P450 suppression by alpha-hederin as a means of protection.
alpha-Hederin pretreatment (30 mu mol/kg, sc x 3 days) protected mice
from acetaminophen-, bromobenzene-, carbon tetrachloride-, furosemide-
, and thioacetamide-induced liver injury, without affecting the hepato
toxicity of chloroform and dimethylnitrosamine. To examine the role of
P450 in hepatoprotection by alpha-hederin, liver microsomes were prep
ared 24 hr following the last dose of alpha-hederin treatment (10 and
30 mu mol/kg, sc x 3 days). Treatment of mice with alpha-hederin produ
ced a dose-dependent suppression of liver cytochrome P450 (30-50%) and
cytochrome b(5) (20-30%) levels, as well as NADPH-cytochrome c reduct
ase activity (15-25%). alpha-Hederin treatment also decreased the acti
vities of P450 enzymes, such as 7-ethoxyresorufin O-dealkylation (65%)
, 7-pentoxyresorufin O-dealkylation (50%), coumarin 7-hydroxylation (4
0%), 7-ethoxycoumarin O-deethylation (45%), caffeine N-3-demethylation
(30-50%), chlorzoxazone 6-hydroxylation (35-55%), and the oxidation o
f testosterone to 2 alpha-, 6 alpha-, 15 alpha-, 15 beta-, 16 alpha-,
16 beta-, and 18/12 alpha-hydroxyltestosterone, androstenedione, and 6
-dehydroxytestosterone (25-60%). Consistent with these observations, t
he levels of CYP1A, CYP2A, and CYP3A enzymes were also suppressed, as
determined by immunoblotting with antibodies against rat P450 enzymes.
These results demonstrate that treatment of mice with alpha-hederin d
ecreases the levels and activities of several P450 enzymes. The suppre
ssion of P450 appears to be one of mechanisms by which alpha-hederin p
rotects mice from the hepatotoxicity of some chemicals. (C) 1995 Acade
mic Press, Inc.